Evidence map›Paper›PMID 19449889›Full record

ArticleJournal of the American Chemical Society2009

Max-E47, a designed minimalist protein that targets the E-box DNA site in vivo and in vitro.

Jing Xu, Gang Chen, Antonia T De Jong, S Hesam Shahravan, Jumi A Shin

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jing XuDepartment of Chemistry, University of Toronto, Mississauga, Ontario L5L 1C6, Canada.
Gang Chen
Antonia T De Jong
S Hesam Shahravan
Jumi A Shin
University of Toronto · CA

Funding

Simplified Helical Proteins that Bind Specific DNA SitesR01GM069041 · NIGMS · UNIVERSITY OF TORONTO · PI SHIN, JUMI A · 2003 to 2006
$644k
Simplified Helical Proteins that Bind Specific DNA SitesR01GM063220 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHIN, JUMI A · 2002 to 2002
$139k
NIGMS NIH HHS R01 GM063220NIGMS NIH HHS R01 GM069041
6 · The paper itself

Abstract

Max-E47 is a designed hybrid protein comprising the Max DNA-binding basic region and E47 HLH dimerization subdomain. In the yeast one-hybrid system (Y1H), Max-E47 shows strong transcriptional activation from the E-box site, 5'-CACGTG, targeted by the Myc/Max/Mad network of transcription factors; two mutants, Max-E47Y and Max-E47YF, activate more weakly from the E-box in the Y1H. Quantitative fluorescence anisotropy titrations to gain free energies of protein:DNA binding gave low nanomolar K(d) values for the native MaxbHLHZ, Max-E47, and the Y and YF mutants binding to the E-box site (14, 15, 9, and 6 nM, respectively), with no detectable binding to a nonspecific control duplex. Because these minimalist, E-box-binding hybrids have no activation domain and no interactions with the c-MycbHLHZ, as shown by the yeast two-hybrid assay, they can potentially serve as dominant-negative inhibitors that suppress activation of E-box-responsive genes targeted by transcription factors including the c-Myc/Max complex. As proof-of-principle, we used our modified Y1H, which allows direct competition between two proteins vying for a DNA target, to show that Max-E47 effectively outcompetes the native MaxbHLHZ for the E-box; weaker competition is observed from the two mutants, consistent with Y1H results. These hybrids provide a minimalist scaffold for further exploration of the relationship between protein structure and DNA-binding function and may have applications as protein therapeutics or biochemical probes capable of targeting the E-box site.

Indexed as

E-Box ElementsAmino Acid SequenceBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsDimerizationDNADNA-Binding ProteinsFluorescence PolarizationHelix-Loop-Helix MotifsModels, MolecularMolecular Sequence DataPlasmidsProtein Structure, TertiaryRecombinant Fusion ProteinsRepressor ProteinsTranscriptional ActivationTranscription FactorsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsDNADNA-Binding ProteinsMNT protein, humanMYCBP protein, humanRecombinant Fusion ProteinsRepressor ProteinsTranscription Factors

Identifiers

PMID19449889
PMCPMC2734406
OpenAlexW1964369521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.